Skip to main content
. 2005 Nov 22;107(5):2200–2207. doi: 10.1182/blood-2005-06-2338

Table 4.

Patient LBP haplotypes in the discovery cohort and their associated risk of significant airflow decline after transplantation

tagSNPs
Haplotype frequencies
Haplotype 541 1598 1756 5584 7400 13506 17002 25276 28559 33158 Controls Cases Odds ratio (95% CI) P values
All patients
1 C A A G T G G C T T 0.325 0.265 Referent
2 T A A G C G A C T C 0.224 0.259 1.44 (0.94-2.19) .091
3 C A A G C G A C T C 0.061 0.06 1.42 (0.72-2.79) .312
4 C A A G T G G C T C 0.051 0.05 1.27 (0.54-2.95) .586
5 C T G G C G A C T C 0.051 0.05 1.14 (0.55-2.37) .724
6 C A A G T G G C A T 0.037 0.04 1.38 (0.61-3.13) .445
7 C A A G T G A C T C 0.037 0.01 0.55 (0.19-1.54) .254
8 T A A G T T A T T C 0.035 0.077 2.8 (1.24-6.34) .014
9 C T A G T G A C T C 0.019 0.015 1.19 (0.27-5.3) .824
10 C T G G C G A C T T 0.008 0.028 4.8 (0.88-26.11) .069
White patients only
1 C A A G T G G C T T 0.337 0.274 Referent
2 T A A G C G A C T C 0.225 0.263 1.38 (0.89-2.13) .149
3 C A A G C G A C T C 0.063 0.067 1.52 (0.77-3.02) .23
4 C T G G C G A C T C 0.05 0.051 1.08 (0.52-2.24) .838
5 C A A G T G G C T C 0.05 0.047 1.14 (0.46-2.88) .775
6 T A A G T T A T T C 0.04 0.083 2.62 (1.15-5.94) .022
7 C A A G T G A C T C 0.037 0.011 0.71 (0.26-1.95) .509
8 C A A G T G G C A T 0.036 0.038 1.24 (0.52-2.95) .624
Donors
1 C A A G T G G C T T 0.299 0.264 Referent
2 T A A G C G A C T C 0.231 0.273 1.32 (0.87-1.99) .194
3 C A A G C G A C T C 0.07 0.047 0.76 (0.36-1.58) .458
4 C A A G T G G C T C 0.057 0.06 1.22 (0.61-2.46) .571
5 C A A G T G G C A T 0.046 0.042 1.05 (0.43-2.6) .913
6 C A A G T G A C T C 0.036 0 0.28 (0.06-1.33) .11
7 T A A G T T A T T C 0.035 0.065 2.2 (0.98-4.91) .055
8 C T G G C G A C T C 0.035 0.053 1.94 (0.82-4.59) .129
9 C T A G T G A C T C 0.024 0.018 0.94 (0.26-3.38) .921
10 T A G A C G G C T C 0.02 0.014 0.71 (0.18-2.88) .635

For all patients, n = 363; for white patients, n = 320; for donors, n = 363. Haplotypes with a P ≤ .05 are shown in italics. All haplotypes were analyzed in multivariate models that included age at transplantation, pretransplantation; FEV1, extent of GVHD, and duration of follow-up as covariates.

— indicates no P value for the group.